High Tech Pharm Co Ltd (106190) Stock Price & News

Why is 106190 down 2.63%?

Dive Deeper

106190:KOSDAQ

High Tech Pharm Co Ltd

₩8,880.00

-2.63%

(-240.00) 1D

Oct 26, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 106190...

Open

₩8,930

High

₩9,090

Low

₩8,600

Mkt. cap

94.42B

Avg. vol.

20.38K

Volume

23.76K

Dividend

1.69%

Quarterly dividend

₩38

Ex-dividend date

Dec 29, 2025

P/E ratio

7.97

52-wk high

₩25,000

52-wk low

₩8,600

EPS

₩1,114

Shares outstanding

10.63M

No. of employees

139

Open

₩8,930

High

₩9,090

Low

₩8,600

Mkt. cap

94.42B

Avg. vol.

20.38K

Volume

23.76K

Dividend

1.69%

Quarterly dividend

₩38

Ex-dividend date

Dec 29, 2025

P/E ratio

7.97

52-wk high

₩25,000

52-wk low

₩8,600

EPS

₩1,114

Shares outstanding

10.63M

No. of employees

139

Related stocks

002210

Dongsung Pharmaceutical Co Ltd

₩1,221.00

-5.28%

334970

Prestige Biologics Co Ltd

₩1,252.00

-0.63%

214390

Kyongbo Pharmaceutical Co Ltd

₩5,170.00

+0.78%

001540

AHN-GOOK PHARMACEUTICAL Co Ltd

₩9,190.00

-0.65%

News stories

From web sources and news partners

Bloomberg.com

10 minutes ago

The War Bump Is a False Victory for S&P 500 Profits

TradingView

41 minutes ago

S&P 500 profit forecasts sprint ahead of stock prices, leaving shares on sale

Yahoo Finance

3 hours ago

Stock Market: Will S&P 500 Open Up or Down Today?

Stocktwits

6 hours ago

Nasdaq Futures Slip Amid Tech Selloff While S&P 500, Dow Edge Higher Ahead Of Crucial Earnings Week: IREN, CRWV, NBIS, MRNA, EWZ In Focus

About High Tech Pharm Co Ltd

CEO-

Employees139

Founded1998

Headquarters-

SectorPharmaceutical industry

Websitehtpharm.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	17.87B	14.04B	14.13B	23.38B
Cost of goods sold	13.06B	9.46B	11.74B	16.17B
Cost of revenue	13.06B	9.46B	11.74B	16.17B
Research and development expenses	-	816.56M	149.93M	205.49M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	867.11M	552.71M	3.29B	650.48M
Operating expense	903.37M	1.41B	3.48B	915.38M
Total operating expenses	13.96B	10.87B	15.22B	17.09B
Operating income	3.91B	3.17B	-1.10B	6.29B
Other non operating income	9.31M	127.18M	58.88M	65.33M
EBT including unusual items	4.61B	3.73B	-376.60M	6.54B
EBT excluding unusual items	4.55B	3.77B	-410.48M	6.53B
Income tax expense	818.46M	573.95M	-109.58M	1.29B
Effective tax rate	17.76%	15.38%	29.10%	19.78%
Other operating expenses	14.62M	15.68M	16.21M	35.09M
Net income	3.79B	3.16B	-267.02M	5.25B
Net profit margin	21.22%	22.50%	-1.89%	22.44%
Earnings per share	-	-	-	-
Interest and investment income	2.72M	4.25M	5.30M	3.61M
Interest expense	-4.81M	-384.00K	-312.00K	-240.00K
Net interest expenses	-2.09M	3.86M	4.98M	3.37M
Depreciation and amortization charges	21.64M	20.76M	21.29M	24.32M
EBITDA	5.27B	4.55B	297.19M	7.70B
Gain or loss from assets sale	-	-	-	-

Ask anything